NDC 37662-0329

Cinnamomum

Cinnamomum

Cinnamomum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Cinnamon.

Product ID37662-0329_e0949e54-9a26-ba0c-e053-2995a90a1cb7
NDC37662-0329
Product TypeHuman Otc Drug
Proprietary NameCinnamomum
Generic NameCinnamomum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-06-03
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameCINNAMON
Active Ingredient Strength6 [hp_C]/1
Pharm ClassesAllergens [CS], Cell-mediated Immunity [PE], Dietary Proteins [CS], Food Additives [CS], Increased Histamine Release [PE], Non-Standardized Food Allergenic Extract [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 37662-0329-1

200 PELLET in 1 VIAL, GLASS (37662-0329-1)
Marketing Start Date2022-06-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Cinnamomum" or generic name "Cinnamomum"

NDCBrand NameGeneric Name
0220-1406CinnamomumCINNAMON
15631-0140CINNAMOMUMCINNAMOMUM
37662-0329CinnamomumCinnamomum
37662-0330CinnamomumCinnamomum
37662-0331CinnamomumCinnamomum
37662-0332CinnamomumCinnamomum
37662-0333CinnamomumCinnamomum
37662-0334CinnamomumCinnamomum
37662-0335CinnamomumCinnamomum
63545-657CinnamomumCinnamomum
68428-322CinnamomumCINNAMON
71919-204CinnamomumCINNAMON

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.